Zobrazeno 1 - 10
of 58
pro vyhledávání: '"Alexander Ring"'
Autor:
Mattheus H. E. Wildschut, Julien Mena, Cyril Dördelmann, Marc van Oostrum, Benjamin D. Hale, Jens Settelmeier, Yasmin Festl, Veronika Lysenko, Patrick M. Schürch, Alexander Ring, Yannik Severin, Michael S. Bader, Patrick G. A. Pedrioli, Sandra Goetze, Audrey van Drogen, Stefan Balabanov, Radek C. Skoda, Massimo Lopes, Bernd Wollscheid, Alexandre P. A. Theocharides, Berend Snijder
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-19 (2023)
Abstract Myelofibrosis is a hematopoietic stem cell disorder belonging to the myeloproliferative neoplasms. Myelofibrosis patients frequently carry driver mutations in either JAK2 or Calreticulin (CALR) and have limited therapeutic options. Here, we
Externí odkaz:
https://doaj.org/article/be42116607d44feb831a5d12924ccd1b
Publikováno v:
healthbook TIMES. Oncology Hematology, Vol 13, Iss 3 (2022)
Plasma cell myeloma (PCM) is a hematopoietic malignancy characterized by the neoplastic proliferation of clonal plasma cells in the bone marrow. High-dose chemotherapy (HDCTx) followed by autologous stem cell transplantation (ASCT) is considered the
Externí odkaz:
https://doaj.org/article/fad2aa38206743c9a8c6ddead6e6e706
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 10 (2022)
Progress in detection and treatment have drastically improved survival for early breast cancer patients. However, distant recurrence causes high mortality and is typically considered incurable. Cancer dissemination occurs via circulating tumor cells
Externí odkaz:
https://doaj.org/article/4db9cdf861064d8c9b3a9af6f7a0d000
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-14 (2020)
Abstract Background Triple negative breast cancer (TNBC) is an aggressive breast cancer subtype with basal features, lacking the expression of receptors targeted successfully in other breast cancer subtypes. Treatment response to adjuvant and neoadju
Externí odkaz:
https://doaj.org/article/7ab77d56795c4265857d15fce7351761
Publikováno v:
healthbook TIMES. Oncology Hematology, Vol 1, Iss 1, Pp 16-21 (2019)
Introduction Diffuse large B-cell lymphoma (DLBCL) is the most common neoplasm of the lymphatic system. Treatment and clinical management are difficult in the relapsed/refractory (R/R) setting. Chimeric antigen receptor (CAR) T cells are genetically
Externí odkaz:
https://doaj.org/article/0edd2761479c45aab7118e8bc5e85c6d
Autor:
Glenn Arendts, Suzanne Robinson, Gill Cowen, Dan Xu, Ashes Mukherjee, Antonio Celenza, Ben Smedley, Michael Bynevelt, Elizabeth Thomas, Stephen Honeybul, Aleksandra Karolina Gozt, Sarah Claire Hellewell, Jacinta Thorne, Francesca Buhagiar, Shaun Markovic, Anoek Van Houselt, Alexander Ring, Sjinene Van Schalkwyk, Philip Brooks, John Iliff, Melissa Licari, Carmela F Pestell, Daniel Fatovich, Melinda Fitzgerald
Publikováno v:
BMJ Open, Vol 11, Iss 5 (2021)
Introduction Mild traumatic brain injury (mTBI) is a complex injury with heterogeneous physical, cognitive, emotional and functional outcomes. Many who sustain mTBI recover within 2 weeks of injury; however, approximately 10%–20% of individuals exp
Externí odkaz:
https://doaj.org/article/af067d57b4d442729f996b639e5b7a93
Autor:
Alexander Ring, Thorsten Zenz
Publikováno v:
Haematologica, Vol 105, Iss 5 (2020)
Externí odkaz:
https://doaj.org/article/f72b05f1c08045d188c65d84867232fd
Autor:
Pushpinder Kaur, Daniel Campo, Tania B. Porras, Alexander Ring, Janice Lu, Yvonne Chairez, Yunyun Su, Irene Kang, Julie E. Lang
Publikováno v:
International Journal of Molecular Sciences, Vol 21, Iss 14, p 4826 (2020)
The comparison of the landscape of somatic alterations in circulating tumor cells (CTCs) versus metastases is challenging. Here, we comprehensively characterized the somatic landscape in bulk (amplified and non-amplified), spike-in breast cancer cell
Externí odkaz:
https://doaj.org/article/ebea07ab8d3d497c87d57df44a199c6f
Publikováno v:
Nature Reviews Cancer, 23 (2)
In recent years, exceptional technological advances have enabled the identification and interrogation of rare circulating tumour cells (CTCs) from blood samples of patients, leading to new fields of research and fostering the promise for paradigm-cha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7cc478af2a5c7d539e0f2a8c109a4adb
https://doi.org/10.5167/uzh-225205
https://doi.org/10.5167/uzh-225205
Autor:
Janice Lu, Pushpinder Kaur, Alexander Ring, Julie E. Lang, Anthony R. Colombo, Irene Kang, Tania B. Porras
Publikováno v:
Br J Cancer
Background Individualising treatment in breast cancer requires effective predictive biomarkers. While relatively few genomic aberrations are clinically relevant, there is a need for characterising patients across different subtypes to identify action
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe9a2b18477c9e1e4133f31302260602
https://doi.org/10.1038/s41416-021-01522-7
https://doi.org/10.1038/s41416-021-01522-7